Events

QB3 “4×4” Bio VC Pitch Session September 2026

Location:

Bakar Labs

Date:

09/30/2026 5:30 pm - 09/30/2026 7:30 pm

Man holding microphone speaks at podium
Decorative graphic promoting September 30 2026 pitch event

What makes an emerging biotech company investable? And more specifically, what most appeals to strategic investors, backing startups whose technologies align with the scope of large pharma?

In QB3’s “4×4” pitch session series, startup founders participating in QB3’s early-stage programs pitch active investors for live feedback in a public setting.

Join us to learn and network with current and future entrepreneurs in UC Berkeley’s vibrant ecosystem.

​VC judges: Shawna Frazier (AbbVie Ventures), Lior Teitelbaum (JJDC), and Tim Luker (Lilly Ventures).

Companies pitching:

  • Adjuva Bio: RNA platform to treat fibrotic disease
  • Inixi Bio: Blocking initiation of hereditary cancers
  • Lucina Biotherapeutics: First-in-class lipid therapies for aging-related disease
  • NeoVariant Bio: In stealth mode
Request to Join

Photos from April 2026 4×4 event at Bakar Bio Labs

Woman and man speaking at podium
Woman holds microphone as she sits at table in panel of four investors
Jon Spalding of Inixi Bio presents at the podium in the Bakar Bio Labs auditorium
Man holding microphone speads at podium
Woman points finger as she asks question, part of public panel discussion
Bakar Bio Labs auditorium full of seated people during presentation